Cargando…

Rare oesophageal tumours: experience of one centre

AIM OF STUDY: The aim of this study is to compare demographic and clinical data as well as applied treatment methods in patients with rare benign and malignant tumours of the oesophagus. METHODS: Eight hundred and thirty patients with oesophageal cancer were treated in the Department of Surgical Onc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielinski, J., Kruszewski, W.J., Jaworski, R., Haponiuk, I., Irga, N., Zygon, J., Kopacz, A., Jaskiewicz, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573716/
https://www.ncbi.nlm.nih.gov/pubmed/23440953
http://dx.doi.org/10.1007/s10353-012-0165-9
_version_ 1782259488967884800
author Zielinski, J.
Kruszewski, W.J.
Jaworski, R.
Haponiuk, I.
Irga, N.
Zygon, J.
Kopacz, A.
Jaskiewicz, J.
author_facet Zielinski, J.
Kruszewski, W.J.
Jaworski, R.
Haponiuk, I.
Irga, N.
Zygon, J.
Kopacz, A.
Jaskiewicz, J.
author_sort Zielinski, J.
collection PubMed
description AIM OF STUDY: The aim of this study is to compare demographic and clinical data as well as applied treatment methods in patients with rare benign and malignant tumours of the oesophagus. METHODS: Eight hundred and thirty patients with oesophageal cancer were treated in the Department of Surgical Oncology in 1960–2005. In 15 cases (1.8 %), rare benign (n = 11) or malignant (n = 4) types of tumours were diagnosed. Patients with rare oesophageal tumours were included in the study, excluding those with squamous cell carcinoma or adenocarcinoma of the oesophagus. Demographic and clinical data were analysed from each patient qualified for the study. Oesophageal X-rays with contrast medium, gastroscopies and, as of 1991, computed tomographies (CTs) were performed as preoperative diagnostic procedures. RESULTS: In the postoperative histopathological examinations, all benign tumours proved to be oesophageal leiomyomas. Four different malignant tumours—a sarcoma, a neuroendocrine carcinoma, a lymphoma, and a squamous cell carcinoma in a patient with Crohn’s disease, were diagnosed in the other four patients. In a group of 15 patients with rare oesophageal tumours there were ten (66.7 %) males and five (33.3 %) females. In patients with benign and malignant tumours, the mean age for the benign group reached 44 years (range: 26–75 years old) and 54.7 years (range: 47–59 years old) for the malignant group. In the preoperative period, symptoms such as swallowing disturbances, retrosternal pains, and epigastric pains were observed. Dysphagia was the leading symptom in patients with benign and malignant oesophageal tumours. Out of 15 patients, surgical procedure was carried out in 13 cases with rare oesophageal tumours. In the group of 11 patients, with benign tumours, ten (90.2 %) warranted surgical treatment. Three patients (75 %) with malignant oesophageal tumours underwent an extensive Akiyama procedure of oesophageal resection. Chemo- and radiotherapy alone were performed on one (25 %) patient with oesophageal lymphoma. Postoperative complications were observed in only four (26.6 %) patients; pneumonia in the postoperative period was diagnosed in two patients who underwent surgery; infections of the postoperative wounds were diagnosed in the other two patients. CONCLUSIONS: Benign oesophageal tumours are characterised by similar clinical symptoms to malignant tumours of this organ. It is more complicated to obtain biopsy specimens for a histopathological examination in cases of benign tumours in comparison to malignant tumours. Treatment methods should be adjusted individually for each patient with a rare oesophageal tumour. For rare benign oesophageal tumours, the results of treatment are very good; however, for malignant tumours the prognosis depends on their histopathological type.
format Online
Article
Text
id pubmed-3573716
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-35737162013-02-21 Rare oesophageal tumours: experience of one centre Zielinski, J. Kruszewski, W.J. Jaworski, R. Haponiuk, I. Irga, N. Zygon, J. Kopacz, A. Jaskiewicz, J. Eur Surg Original Article AIM OF STUDY: The aim of this study is to compare demographic and clinical data as well as applied treatment methods in patients with rare benign and malignant tumours of the oesophagus. METHODS: Eight hundred and thirty patients with oesophageal cancer were treated in the Department of Surgical Oncology in 1960–2005. In 15 cases (1.8 %), rare benign (n = 11) or malignant (n = 4) types of tumours were diagnosed. Patients with rare oesophageal tumours were included in the study, excluding those with squamous cell carcinoma or adenocarcinoma of the oesophagus. Demographic and clinical data were analysed from each patient qualified for the study. Oesophageal X-rays with contrast medium, gastroscopies and, as of 1991, computed tomographies (CTs) were performed as preoperative diagnostic procedures. RESULTS: In the postoperative histopathological examinations, all benign tumours proved to be oesophageal leiomyomas. Four different malignant tumours—a sarcoma, a neuroendocrine carcinoma, a lymphoma, and a squamous cell carcinoma in a patient with Crohn’s disease, were diagnosed in the other four patients. In a group of 15 patients with rare oesophageal tumours there were ten (66.7 %) males and five (33.3 %) females. In patients with benign and malignant tumours, the mean age for the benign group reached 44 years (range: 26–75 years old) and 54.7 years (range: 47–59 years old) for the malignant group. In the preoperative period, symptoms such as swallowing disturbances, retrosternal pains, and epigastric pains were observed. Dysphagia was the leading symptom in patients with benign and malignant oesophageal tumours. Out of 15 patients, surgical procedure was carried out in 13 cases with rare oesophageal tumours. In the group of 11 patients, with benign tumours, ten (90.2 %) warranted surgical treatment. Three patients (75 %) with malignant oesophageal tumours underwent an extensive Akiyama procedure of oesophageal resection. Chemo- and radiotherapy alone were performed on one (25 %) patient with oesophageal lymphoma. Postoperative complications were observed in only four (26.6 %) patients; pneumonia in the postoperative period was diagnosed in two patients who underwent surgery; infections of the postoperative wounds were diagnosed in the other two patients. CONCLUSIONS: Benign oesophageal tumours are characterised by similar clinical symptoms to malignant tumours of this organ. It is more complicated to obtain biopsy specimens for a histopathological examination in cases of benign tumours in comparison to malignant tumours. Treatment methods should be adjusted individually for each patient with a rare oesophageal tumour. For rare benign oesophageal tumours, the results of treatment are very good; however, for malignant tumours the prognosis depends on their histopathological type. Springer Vienna 2012-11-20 2012-12 /pmc/articles/PMC3573716/ /pubmed/23440953 http://dx.doi.org/10.1007/s10353-012-0165-9 Text en © The Author(s) 2012
spellingShingle Original Article
Zielinski, J.
Kruszewski, W.J.
Jaworski, R.
Haponiuk, I.
Irga, N.
Zygon, J.
Kopacz, A.
Jaskiewicz, J.
Rare oesophageal tumours: experience of one centre
title Rare oesophageal tumours: experience of one centre
title_full Rare oesophageal tumours: experience of one centre
title_fullStr Rare oesophageal tumours: experience of one centre
title_full_unstemmed Rare oesophageal tumours: experience of one centre
title_short Rare oesophageal tumours: experience of one centre
title_sort rare oesophageal tumours: experience of one centre
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573716/
https://www.ncbi.nlm.nih.gov/pubmed/23440953
http://dx.doi.org/10.1007/s10353-012-0165-9
work_keys_str_mv AT zielinskij rareoesophagealtumoursexperienceofonecentre
AT kruszewskiwj rareoesophagealtumoursexperienceofonecentre
AT jaworskir rareoesophagealtumoursexperienceofonecentre
AT haponiuki rareoesophagealtumoursexperienceofonecentre
AT irgan rareoesophagealtumoursexperienceofonecentre
AT zygonj rareoesophagealtumoursexperienceofonecentre
AT kopacza rareoesophagealtumoursexperienceofonecentre
AT jaskiewiczj rareoesophagealtumoursexperienceofonecentre